A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer

Overview of attention for article published in Value in Health (Elsevier Science), March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy: 1 policy source
twitter: 8 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 129 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 03 Mar 2017

#HealthEconJA A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer